stock market tips today

Stock Market Free Tips – Recommendation, stock market tips today, Expert Advice, Technical & Fundamental Analysis, Latest Update, News, Stock, Shares, IPO, World Market, Investment Guru, F&O, Nifty, Bank Nifty, Sensex, NSE, BSE, Equity, Trading, Buy, Sell, Tips, Forecast. stock market tips for intraday free, free stock market tips for tomorrow, share market tips for beginners, free stock tips on whatsapp, free share market tips on mobile, how to invest in share market, best intraday tips, shares to buy today in indian market, share market tips for beginners, free share market tips on mobile, share market tips in hindi, shares to buy today in indian market, stock market tips for intraday free, free stock market tips for tomorrow, free stock tips on whatsapp, how to invest in share market, Amber Enterprises India Share Price, Bank of Baroda Share Price, BEML Share Price, Cadila Healthcare Share Price, Central Bank of India Share Price, Engineers India Share Price, jubilant food share price, pvr share price, General Insurance Corporation of India Share Price, India Cements Share Price, mcdowell share price, SRF Share Price, Indian Hotels Share Price, Jagran Prakashan Share Price, Karur Vysya Bank Share Price, Lakshmi Vilas Bank Share Price, Lemon Tree Hotels Share Price, Max Financial Services Share Price, NBCC Share Price, NLC India Share Price, Page Industries Share Price, PC Jeweller Share Price, PFC Share Price, Va Tech Wabag Share Price, Waterbase Share Price

Ajanta Pharma Share Price – Keep Eye on ₹1018 level Below No Buying @all – Sell 1Laks, 2 Laks Lots – Aur So Jaaooooooooo – Hint Call By Market Guru Neal Bhai

by

Ajanta Pharma Share Price – Keep Eye on ₹1018 level Below No Buying @all – Sell 1Laks, 2 Laks Lots – Aur So Jaaooooooooo – Hint Call By Market Guru Neal Bhai

“No Magic, No Miracle, Just Power of Level”

Neal Bhai Reports (NBR) By CFA’s  and MFA’s Technical Team

Mobile No. 9582247600 & 9899900589

Read More →

Cipla Rises On U.S. FDA Nod For Immunodeficiency Drug

by

Neal Bhai Reports (NBR) — Cipla Rises On U.S. FDA Nod For Immunodeficiency Drug – Shares of the Mumbai-based drugmaker rose as much as 6.47 percent to Rs 622.75 after U.S. FDA gave its final approval to Efavirenz tablets in strength of 600 mg. Efavirenz Tablets 600 mg is AB-rated generic therapeutic equivalent version of Bristol-Myers Squibb Pharma Company’s Sustiva which is used in treatment of human immunodeficiency virus type 1 infection, Cipla said in an exchange filing.

Read More →